About Sino Biological
Sino Biological (301047.SZ) specializes in the development of process and manufacturing technologies for biological products such as recombinant proteins, monoclonal antibodies, vaccines, and gene therapy products. The company offers a full set of proprietary platform technologies for rapid and cost-effective development of biological products starting from a target gene.
Missing: Sino Biological's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Sino Biological's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Sino Biological
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Sino Biological is included in 1 Expert Collection, including Regenerative Medicine.
Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).
Latest Sino Biological News
Dec 1, 2022
Sino Biological has begun construction of its first US-based manufacturing facility at a 53-acre life science district in Houston.
Sino Biological Web Traffic
Sino Biological Rank
Sino Biological Frequently Asked Questions (FAQ)
When was Sino Biological founded?
Sino Biological was founded in 2016.
Where is Sino Biological's headquarters?
Sino Biological's headquarters is located at Building 9, No. 18, Kechuang 10th Street, Beijing.
What is Sino Biological's latest funding round?
Sino Biological's latest funding round is IPO.
How much did Sino Biological raise?
Sino Biological raised a total of $29M.
Who are the investors of Sino Biological?
Investors of Sino Biological include Qingsong Capital, Ningbo Meishan Bonded Port Area Nanli Investment and Qiming Venture Partners.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.